Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry
Authors:ID Gautier, Alexandre (Author)
ID Picard, Fabien (Author)
ID Ducrocq, Gregory (Author)
ID Elbez, Yedid (Author)
ID Fox, Kim M. (Author)
ID Ferrari, Roberto (Author)
ID Ford, Ian (Author)
ID Tardif, Jean-Claude (Author)
ID Tendera, Michaĺ (Author)
ID Steg, Philippe Gabriel (Author)
ID Fras, Zlatko (Research coworker), et al.
Files:.pdf PDF - Presentation file, download (916,51 KB)
MD5: 57C6ABB580CEE358641C9D32544FFC60
 
URL URL - Source URL, visit https://academic.oup.com/eurheartj/article/45/5/366/7249155?login=false
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Background and aims: Data on new-onset atrial fibrillation (NOAF) in patients with chronic coronary syndromes (CCS) are scarce. This study aims to describe the incidence, predictors, and impact on cardiovascular (CV) outcomes of NOAF in CCS patients. Methods: Data from the international (45 countries) CLARIFY registry (prospeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease) were used. Among 29 001 CCS outpatients without previously reported AF at baseline, patients with at least one episode of AF/flutter diagnosed during 5-year follow-up were compared with patients in sinus rhythm throughout the study. Results: The incidence rate of NOAF was 1.12 [95% confidence interval (CI) 1.06-1.18] per 100 patient-years (cumulative incidence at 5 years: 5.0%). Independent predictors of NOAF were increasing age, increasing body mass index, low estimated glomerular filtration rate, Caucasian ethnicity, alcohol intake, and low left ventricular ejection fraction, while high triglycerides were associated with lower incidence. New-onset atrial fibrillation was associated with a substantial increase in the risk of adverse outcomes, with adjusted hazard ratios of 2.01 (95% CI 1.61-2.52) for the composite of CV death, non-fatal myocardial infarction, or non-fatal stroke, 2.61 (95% CI 2.04-3.34) for CV death, 1.64 (95% CI 1.07-2.50) for non-fatal myocardial infarction, 2.27 (95% CI 1.85-2.78) for all-cause death, 8.44 (95% CI 7.05-10.10) for hospitalization for heart failure, and 4.46 (95% CI 2.85-6.99) for major bleeding. Conclusions: Among CCS patients, NOAF is common and is strongly associated with worse outcomes. Whether more intensive preventive measures and more systematic screening for AF would improve prognosis in this population deserves further investigation.
Keywords:atrial fibrilation, chronic coronary syndrome, coronary artery disease, risk assessment
Publication status:Published
Publication version:Version of Record
Year of publishing:2024
Number of pages:str. 366-375
Numbering:Vol. 45, no. 5
PID:20.500.12556/DiRROS-29832 New window
UDC:616.1
ISSN on article:0195-668X
DOI:10.1093/eurheartj/ehad556 New window
COBISS.SI-ID:226401795 New window
Note:
Publication date in DiRROS:08.06.2026
Views:109
Downloads:103
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:European heart journal
Shortened title:Eur. heart j.
Publisher:University Press
ISSN:0195-668X
COBISS.SI-ID:25424896 New window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Secondary language

Language:Slovenian
Keywords:atrijska fibrilacija, kronični koronarni sindrom, bolezen koronarnih arterij, ocena tveganja


Back